Publication | Open Access
Tumor-associated macrophages promote resistance of hepatocellular carcinoma cells against sorafenib by activating CXCR2 signaling
61
Citations
30
References
2022
Year
This study identified CXCL1, CXCL2, and their downstream CXCR2/ERK signaling as potential therapeutic targets to overcome SOR resistance in HCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1